Physicians and researchers say more data is needed on pregnancy outcomes in patients taking GLP-1s as a growing number of women turn to the class of weight loss medications in hopes of reducing their risk of pregnancy complications or increasing their chance of conceiving, Bloomberg reported April 18.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
